Provided by Tiger Trade Technology Pte. Ltd.

Cardiol Therapeutics Inc

1.90
+0.05002.70%
Pre-market: 1.900.00000.00%06:09 EDT
Volume:1.58M
Turnover:2.92M
Market Cap:229.90M
PE:-8.05
High:1.90
Open:1.85
Low:1.81
Close:1.85
52wk High:2.34
52wk Low:0.8800
Shares:121.00M
Float Shares:95.81M
Volume Ratio:1.05
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2360
EPS(LYR):-0.2835
ROE:-190.18%
ROA:-90.92%
PB:13.39
PE(LYR):-6.70

Loading ...

Company Profile

Company Name:
Cardiol Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
18
Office Location:
2265 Upper Middle Road East,Suite 602,Oakville,Ontario,Canada
Zip Code:
L6H 0G5
Fax:
- -
Introduction:
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.